In the last few years' immunotherapy has become an important cancer treatment option. While the principles of immunotherapy evolved, only sipuleucel-T was approved by the Food and Drug Administration (FDA) which lead to further studies with other agents, starting a new era in immuno-oncology. A...
Prostate Cancer Treatment Overview This year in the United States, there will be over 230,000 new prostate cancer diagnoses, making prostate cancer the most common type of cancer affecting men. Chances are either you or someone you know will develop the disease. ...
According to Dr. Raman, "This image-guided therapy maximizes our ability to killcancer cellswhile minimizingcollateral damageto the prostate to achieve the ultimate trifecta inprostate cancer treatment: full local cancer control while maintaining urinary continence and potency. The latter are the complic...
CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed,...
The treatment plan for prostate cancer depends on the size, location, extent of the disease, and the patient’s physical condition. In St. Stamford Modern Cancer Hospital Guangzhou, experts from Multidisiplinary Team (MDT) will jointly hold a consultation and discuss appropriate treatment options ...
Prostate cancer is a hormone-dependent malignancy, whose onset and progression are closely related to the activity of the androgen receptor (AR) signaling pathway. Due to this critical role of AR signaling in driving prostate cancer, therapy targeting th
Despite advances in the screening and treatment of prostate cancer, the therapy options available, particularly for later stages of the disease, remain limited, and the treatment-resistant setting represents a serious unmet medical need. Moreover, diseas
Prostate cancer is the most common form of cancer in men in Western countries. There are approximately 1.1 million new cases around the world per year, and approx. 310,000 die from prostate cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 195...
Prostate cancer, disease characterized by uncontrolled growth of cells within the prostate gland. Prostate cancer is a frequently diagnosed cancer among males. Learn more about the causes, symptoms, and treatment of prostate cancer.
The recent successful development of poly ADP-ribose polymerase (PARP) inhibitors for patients with mCRPC and mutations in DNA damage repair genes has added to the treatment armamentarium and improved personalized treatments for prostate cancer. Other promising therapeutic agents currently in clinical ...